Skip to main content

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 226 matches for

New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia

RDM researchers have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.

New research will map the impact of sleep and circadian rhythm disruption on cardiometabolic disease

In the UK more than 4.3 million people live with Type-2 Diabetes, and 2.4 million more are at increased risk of developing the disease. Type-2 Diabetes, obesity, hypertension, and fatty liver disease frequently cluster together in the same individuals. It is becoming clear that sleep and body clock problems ha…

Professor Charalambos Antoniades elected as new Fellow of the Academy of Medical Sciences

The Academy of Medical Sciences has elected five University of Oxford biomedical and health scientists to its fellowship in 2025, including Charis Antoniades.

Study identifies key immune structures in the gut that may drive coeliac disease

Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.

RDM researchers edit new edition of seminal haematology textbook

Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.

Wellcome Career Development Award For Agne Antanaviciute

Dr Agne Antanaviciute has won a Wellcome Career Development Award for her research investigating early-life immunity.

Landmark study finds no benefit of routine use of cerebral embolic protection devices on TAVI stroke risk

Researchers say the devices cannot be recommended for routine clinical use in the UK.

New study reveals details of key immune mechanism

An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.

Ancient genomic linkage regulates red blood cell development

A collaboration between the Drakesmith and Higgs Groups at the MRC Weatherall Institute of Molecular Medicine has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.

Wellcome Career Development Award For Sumana Sharma

Dr Sumana Sharma has won a Wellcome Career Development Award for her research investigating receptors in T cells.

New research findings help identify those most at risk of developing hypertrophic cardiomyopathy

Two new research papers, published in Nature Genetics, jointly led by RDM’s Professor Hugh Watkins, have further advanced our understanding of the genetic basis of hypertrophic cardiomyopathy (HCM).

Clinical trials begin for a first-in-class, inhaled gene therapy for people with cystic fibrosis

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

RDM researchers collaborate on postpartum blood pressure self-monitoring trial in the US

Researchers in RDM’s Cardiovascular Clinical Research Facility (CCRF) will collaborate with the University of Pennsylvania on a new trial to understand the potential benefits of postpartum blood pressure monitoring in the US healthcare system.

Researchers provide a perspective on mapping the bone marrow using new spatial transcriptomic technologies

RDM researchers have outlined the potential benefits and limitations of new spatial transcriptomic technologies for mapping the bone marrow in patients with blood cancer.

Support for RDM research in diagnosing and managing heart failure

The Kusuma Trust has made an award of £400K to fund research in diagnosing and managing heart failure.

Study to evaluate treatment of Autonomous Cortisol Secretion

New MRC Centre to create cutting-edge gene therapies

Professor Deborah Gill is to co-lead an MRC research centre being launched to develop new advanced treatments for currently untreatable diseases.

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an i…

Davis Group receives Wellcome Discovery Award

Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.

Transformative treatments for children with fatal genetic lung diseases

AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.

Load More